Incidence of de novo gastroesophageal reflux disease following sleeve gastrectomy versus sleeve gastrectomy with transit bipartition: a retrospective cohort study.
{"title":"Incidence of de novo gastroesophageal reflux disease following sleeve gastrectomy versus sleeve gastrectomy with transit bipartition: a retrospective cohort study.","authors":"Jian Wang, Liangchen Ni, Tianci Li, Wanjie Wang, Wenchao Song, Fidele Kakule Kitaghenda, Jian Hong, Xiaocheng Zhu, Libin Yao","doi":"10.1007/s00464-025-12276-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sleeve gastrectomy (SG) is the most commonly performed bariatric procedure worldwide; however, concerns persist regarding the development of de novo gastroesophageal reflux disease (GERD) after surgery. Sleeve gastrectomy with transit bipartition (SG-TB) has emerged as a potential alternative, aiming to reduce GERD incidence while achieving superior weight loss outcomes. This study aimed to compare short-term outcomes of GERD, weight loss, and perioperative safety between SG and SG-TB.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted with 215 patients who underwent SG (n = 100) or SG-TB (n = 115) between January and December 2022. Eligible patients were aged 16-65 years with a body mass index (BMI) of ≥ 27.5 kg/m<sup>2</sup> (with type 2 diabetes) or ≥ 32.5 kg/m<sup>2</sup>. GERD incidence was evaluated using the gastroesophageal reflux disease questionnaire (GERD-Q) and endoscopy 12 months after surgery. Weight loss was measured by percentage total weight loss (%TWL) and percentage excess weight loss (%EWL). Operative time, estimated blood loss, length of hospital stay, and 30-day postoperative complications were also compared.</p><p><strong>Results: </strong>At 12 months, the SG-TB group demonstrated superior weight loss (%EWL: 112.0 ± 38.2% vs. 97.2 ± 25.5%, p = 0.001; %TWL: 33.8 ± 7.4% vs. 31.1 ± 6.4%, p = 0.006). The incidence of GERD was significantly lower in the SG-TB group (7.0% vs. 29.0%, p < 0.001). Multivariate regression analysis identified SG as an independent risk factor for developing de novo GERD postoperatively (OR 4.536, 95% CI 1.787-11.519, p = 0.001). SG-TB was associated with longer operative time but showed comparable early postoperative safety to SG.</p><p><strong>Conclusions: </strong>SG-TB significantly reduced the risk of postoperative GERD and resulted in superior short-term weight loss compared to SG, without increasing perioperative complication rates. Further multicenter, long-term studies are needed to validate these findings.</p>","PeriodicalId":22174,"journal":{"name":"Surgical Endoscopy And Other Interventional Techniques","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Endoscopy And Other Interventional Techniques","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00464-025-12276-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Sleeve gastrectomy (SG) is the most commonly performed bariatric procedure worldwide; however, concerns persist regarding the development of de novo gastroesophageal reflux disease (GERD) after surgery. Sleeve gastrectomy with transit bipartition (SG-TB) has emerged as a potential alternative, aiming to reduce GERD incidence while achieving superior weight loss outcomes. This study aimed to compare short-term outcomes of GERD, weight loss, and perioperative safety between SG and SG-TB.
Methods: A retrospective cohort study was conducted with 215 patients who underwent SG (n = 100) or SG-TB (n = 115) between January and December 2022. Eligible patients were aged 16-65 years with a body mass index (BMI) of ≥ 27.5 kg/m2 (with type 2 diabetes) or ≥ 32.5 kg/m2. GERD incidence was evaluated using the gastroesophageal reflux disease questionnaire (GERD-Q) and endoscopy 12 months after surgery. Weight loss was measured by percentage total weight loss (%TWL) and percentage excess weight loss (%EWL). Operative time, estimated blood loss, length of hospital stay, and 30-day postoperative complications were also compared.
Results: At 12 months, the SG-TB group demonstrated superior weight loss (%EWL: 112.0 ± 38.2% vs. 97.2 ± 25.5%, p = 0.001; %TWL: 33.8 ± 7.4% vs. 31.1 ± 6.4%, p = 0.006). The incidence of GERD was significantly lower in the SG-TB group (7.0% vs. 29.0%, p < 0.001). Multivariate regression analysis identified SG as an independent risk factor for developing de novo GERD postoperatively (OR 4.536, 95% CI 1.787-11.519, p = 0.001). SG-TB was associated with longer operative time but showed comparable early postoperative safety to SG.
Conclusions: SG-TB significantly reduced the risk of postoperative GERD and resulted in superior short-term weight loss compared to SG, without increasing perioperative complication rates. Further multicenter, long-term studies are needed to validate these findings.
期刊介绍：
Uniquely positioned at the interface between various medical and surgical disciplines, Surgical Endoscopy serves as a focal point for the international surgical community to exchange information on practice, theory, and research.
Topics covered in the journal include:
-Surgical aspects of:
Interventional endoscopy,
Ultrasound,
Other techniques in the fields of gastroenterology, obstetrics, gynecology, and urology,
-Gastroenterologic surgery
-Thoracic surgery
-Traumatic surgery
-Orthopedic surgery
-Pediatric surgery
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
